Novogen Limited (KZIA)
(Delayed Data from NSDQ)
$0.28 USD
+0.01 (3.44%)
Updated May 24, 2024 03:39 PM ET
After-Market: $0.28 0.00 (0.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Novogen Limited [KZIA]
Reports for Purchase
Showing records 41 - 46 ( 46 total )
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
GDC-0084 and Cantrixil trials progressing
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
GDC-0084 and Cantrixil trials progressing
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Novogen Limited
Industry: Medical - Drugs
GDC-0084 Phase II underway
Provider: EDISON INVESTMENT RESEARCH LIMITED
Company: Novogen Limited
Industry: Medical - Drugs
We are discontinuing coverage of due to better allocate resources within our coverage universe
Provider: H.C. Wainwright & Co., Inc.